DAVID GRYSKA

Profile

First Name

: DAVID

Middle Name

:

Last Name

: GRYSKA

Related Companies
Titles
Company Name
Related People
DIRECTOR
HYPERION THERAPEUTICS INC
GAURAV AGGARWAL, DION COAKLEY, KLARA DICKINSON, KLARA A. DICKINSON, JEFFREY FARROW, JEFFREY S. FARROW, ASHLEY GOULD, BO JESPER HANSEN, BO JESPER HANSEN, JAMES HEALY, JAMES I. HEALY, JIM HEALY, NATALIE HOLLES, ROB HOPFNER, ROBERT HOPFNER, TONI MARTINEZ, MASOUD MOKHTARANI, CHRISTINE NASH, CHRISTINE A. NASH, JAKE NUNN, JAKE R. NUNN, DANIEL PEREZ, BIJAN SALEHIZADEH, DON SANTEL, DONALD SANTEL, DONALD J. SANTEL, BRUCE SCHARSCHMIDT, BRUCE F. SCHARSCHMIDT, DANIEL G. WELCH, LOTA ZOTH, LOTA S. ZOTH
DIRECTOR
ARGOS THERAPEUTICS INC
JEFFREY D. ABBEY, HUBERT BIRNER, B. JEFFERSON CLARK, MICHEL GRECO, LORI HARRELSON, INES HOLZBAUR, MONIQUE LALIBERTE, JEAN LAMARRE, FREDERICK M. MIESOWICZ, CHARLES A. NICOLETTE, ANDREI PETROV, DOUGLAS PLESSINGER, PHILIP R. TRACY, BRIAN UNDERDOWN, SANDER VAN DEVENTER
DIRECTOR
AERIE PHARMACEUTICALS INC
VICENTE ANIDO, GERALD CAGLE, JANET CONWAY, MITCHELL DELONG, GEOFFREY DUYK, DAVID EPSTEIN, MURRAY GOLDBERG, DENNIS HENNER, CASEY KOPCZYNSKI, BRIAN LEVY, DAVID MACK, JAMES MAZZO, ANAND MEHRA, THOMAS MITRO, THOMAS J MITRO, RICHARD RUBINO, THOMAS VAN HAARLEM, THOMAS J VAN HAARLEM
DIRECTOR
FORTE BIOSCIENCES, INC.
FRANKLIN M. BERGER, DENNIS BERMAN, SCOTT BRUN, HUBERT CHEN, THOMAS DARCY, STEPHEN DOBERSTEIN, MARTIN J DUVALL, LAWRENCE EICHENFIELD, BARBARA FINK, MARK FOLETTA, HARRY GRUBER, FAHEEM HASNAIN, DOUGLAS JOLLY, STEVEN KORNFELD, LORI KUNKEL, DAVID R. PARKINSON, ANTONY RILEY, PAUL R. SCHIMMEL, PAUL WAGNER, DONALD WILLIAMS
DIRECTOR
MIND MEDICINE (MINDMED) INC.
ROBERT BARROW, SUZANNE BRUHN, ROGER CRYSTAL, PERRY DELLELCE, STANLEY GLICK, SCHOND GREENWAY, STEPHEN HURST, DANIEL KARLIN, ANDREAS KREBS, CARRIE LIAO, BRUCE LINTON, BRIGID MAKES, JAMON ALEXANDER RAHN, JAMON ALEXANDER RAHN, MARK R. SULLIVAN, CAROL A. VALLONE, MIRI HALPERIN WERNLI, MIRIAM HALPERIN WERNLI, MIRIAM HALPERIN WERNLI, MATT WILEY
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-05-05
D
Link
PHARMACEUTICALS 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Equity 
2023-08-11 
2024-03-18
D
Link
PHARMACEUTICALS 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Equity 
2024-03-11 
2023-08-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-07-31 
2014-09-23
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2014-09-08 
2013-08-29
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2012-12-07 
2013-08-27
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-08-09 
2012-12-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-12-07 
2012-09-11
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-08-31 
2012-04-24
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-04-10 
2011-11-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-10-26 
2011-04-18
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-04-01